Novedades

Source: The New York Times

Why Are So Few Blockbuster Drugs Invented Today?

One possibility mentioned in the proposal was the development of a kind of insulin that would automatically respond to changes in blood-sugar levels, becoming active only when needed to maintain healthy levels around the clock. If it worked, the sugar-sensitive version could transform the lives of the six million people with diabetes in the United States who use insulin. No longer would they have to test their blood-sugar levels multiple times per day and try to calculate how much insulin to take. The self-regulating insulin would curtail high sugar levels, which raise the risk of long-term complications, and eradicate, or at least reduce, the most dangerous short-term complication: hypoglycemia, when sugar levels fall so low that they can cause confusion, unconsciousness, seizures and even death.

Why Are So Few Blockbuster Drugs Invented Today? Read More »

Marcelo Figueiras recibió el premio Desarrollos tecnológicos innovadores en el área farmacológica

Marcelo Figueiras recibió el premio Desarrollos tecnológicos innovadores en el área farmacológica

La Fundación para la Interacción de los Sistemas Productivos Educativo Científico Tecnológico (FUNPRECIT) le otorgó este jueves pasado al presidente de Laboratorios Richmond, Marcelo Figueiras, el premio \”Desarrollos Tecnológicos innovadores en el Área Farmacológica\”.

Marcelo Figueiras recibió el premio Desarrollos tecnológicos innovadores en el área farmacológica Read More »

Unitaid Logo

HIV treatment successes lead to new challenges, opportunities in confronting chronic disease

They are illnesses that will increasingly challenge health systems in low and middle income countries, and call for new responses, authors of the 8 articles and 2 commentaries within the edition write, but at the same time, those responses can benefit from groundwork already laid in HIV responses.

HIV treatment successes lead to new challenges, opportunities in confronting chronic disease Read More »

Logo Revista Nature

Should experimental drugs be used in the Ebola outbreak?

Two Liberian doctors are set to become the first Africans to receive an experimental drug against the Ebola virus. Once they are treated, existing supplies of the drug, ZMapp, will be exhausted. The news comes as the World Health Organization (WHO) concludes that it is ethical to use unproven treatments in the current outbreak in West Africa, the biggest outbreak of Ebola since records began, which had killed 1,013 people by 9 August.

Should experimental drugs be used in the Ebola outbreak? Read More »

Logo Revista Nature

Supercooled livers last for days

When a human donor organ becomes available, transplant surgeons have only about 12 hours to collect and transplant the tissue before it breaks down. But a slow-cooling method that first chills rat livers and then drops the temperature to below freezing — allowing them to be stored in a \’supercooled\’ but non-frozen state — keeps them fresh for three days. If the method works for human organs, it could drastically increase the number that are available for transplantation.

Supercooled livers last for days Read More »

Logo Revista Nature

Capacity building: Architects of South American science

Regional and cross-continental networks strengthen science in South America. They encourage young scientists to return home, motivate governments to invest in their own science, and fill gaps in core technologies such as advanced microscopy and proteomics, which require sophisticated instruments. A number of initiatives in recent years illustrate several creative approaches.

Capacity building: Architects of South American science Read More »

Scroll al inicio